Terpenoid-mediated modulation of regulatory immune cells in the tumor microenvironment
Cancer constitutes the primary and foremost cause of death globally. Despite the emergence of numerous contemporary therapies alongside traditional therapy, mortality rates continue to escalate. Recently, immunotherapy has emerged as an attractive and advantageous method for cancer treatment. Despite its increasing use in the treatment of various cancer types, its efficacy varies considerably and is not uniformly superior to conventional treatment methods. Not every patients or tumor types responds effectively to immunotherapy. Increasing evidence indicates that this limited efficacy may be directly associated with immunosuppressive tumor microenvironment (TME). TME constitutes a dynamic immunological niche that regulates carcinogenesis, progression, and metastasis through various types of regulatory immune cells. These cells include myeloid-derived suppressor cells (MDSCs), regulatory T cells (Treg), and tumor-associated macrophages (TAMs) which foster immune evasion by repressing effective antitumor responses. An emerging class of plant-based anticancer compounds, terpenoids, have recently attracted attention for their potential immunomodulatory and anticancer properties. While previous research has mainly investigated their direct cytotoxic effects on tumor cells, recent findings from preclinical in vitro and in vivo studies suggest that terpenoids may also modulate immune regulatory networks within the TME. This narrative review provides a mechanistic overview of immunomodulatory potential of plant-derived terpenoids by regulating the activity of regulatory T cells (Treg) and myeloid-derived suppressor cells (MDSCs) within the TME in preclinical cancer models. It also highlighted the molecular mechanisms underlying plant-derived-induced alterations in Treg and MDSCs activity and function, including changes in signaling pathways, transcriptional regulatory factors, and cytokine mediated pathways.
Authors
- Shakilur Rahman (ORCID: https://orcid.org/0000-0003-4155-9479)
- Meenakshi Verma (ORCID: https://orcid.org/0000-0002-2407-0818)
- Pratibha Pandey (ORCID: https://orcid.org/0000-0001-7029-8517)
- Fahad Khan (ORCID: https://orcid.org/0000-0003-3449-7978)
- Md Ali Mujtaba (ORCID: https://orcid.org/0000-0002-6372-890X)
- Sorabh Lakhanpal (ORCID: https://orcid.org/0000-0001-8375-4702)
- Shailendra Thapliyal (ORCID: https://orcid.org/0009-0002-6212-2057)
- Mohammad Alzahrani (ORCID: https://orcid.org/0009-0004-6137-6498)
Institutions
- Chandigarh University (IN)
- Lovely Professional University (IN)
- Northern Border University (SA)
- Imam Mohammad ibn Saud Islamic University (SA)
- Uttaranchal University (IN)
- Al Baha University (SA)
- Saveetha University (IN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3389/fphar.2026.2034678
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00